DEA Extends Telemedicine for Prescribing Controlled Meds as Pandemic Measures End
WEDNESDAY, May 10, 2023 (HealthDay News) — The U.S. Drug Enforcement Administration on Wednesday issued a six-month extension for people seeking to fill controlled medication prescriptions via telehealth. That ability had been set to expire along wit…
Learn MoreDupilumab Beneficial for Adults With Prurigo Nodularis
WEDNESDAY, May 10, 2023 (HealthDay News) — For adults with prurigo nodularis (PN), dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin (IL)-4 and IL-13, demonstrates clinically meaningful and signifi…
Learn MoreDEA Extends Telemedicine for Prescribing Controlled Meds as Pandemic Measures End
WEDNESDAY, May 10, 2023 (HealthDay News) – The U.S. Drug Enforcement Administration on Wednesday issued a six-month extension for people seeking to fill controlled medication prescriptions via telehealth.That ability had been set to expire along with …
Learn MoreEl fabricante de Wegovy limita el suministro del fármaco para la obesidad en EE. UU.
VIERNES, 5 de mayo de 2023 (HealthDay News) — Novo Nordisk, la compañía farmacéutica danesa, anunció el jueves que limitará la distribución de sus versiones de dosis bajas del popularísimo medicamento para perder peso Wegovy, para garantizar que las …
Learn MoreMaker of Wegovy Limits Supply of Obesity Drug in the United States
FRIDAY, May 5, 2023 (HealthDay News) — Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough suppl…
Learn More¿Todos los sobrevivientes a un ataque cardiaco necesitan betabloqueadores?
JUEVES, 4 de mayo de 2023 (HealthDay News) — El estándar es que los sobrevivientes a un ataque cardiaco tomen betabloqueadores durante años, pero un nuevo estudio sugiere que quizá esto sea innecesario para las personas que hayan tenido un ataque car…
Learn MoreIntensive BP Targets Cut Risk for Cardiac Conduction Disease
FRIDAY, May 5, 2023 (HealthDay News) — Intensive blood pressure control is associated with a lower risk for left ventricular conduction disease, according to a study published online May 3 in JAMA Cardiology.Emilie K. Frimodt-Møller, M.D., from the U…
Learn MoreMaker of Wegovy Limits Supply of Obesity Drug in U.S.
FRIDAY, May 5, 2023 (HealthDay News) – Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply…
Learn MoreReport IDs Those Likely to Receive Meds for Opioid Use Disorder in Pregnancy
THURSDAY, May 4, 2023 (HealthDay News) — Persons receiving medication for opioid use disorder (MOUD) in pregnancy are more likely to be older and White and to have public insurance, according to research published in the May 5 issue of the U.S. Cent…
Learn MoreDo All Heart Attack Survivors Need Long-Term Beta Blocker Meds?
THURSDAY, May 4, 2023 (HealthDay News) — It’s standard for heart attack survivors to take beta blocker medications for years afterward, but a new study suggests that may be unnecessary for people who’ve had a milder heart attack. Researchers found th…
Learn More